Lost Password? No account yet? Register

Advertisement

New Media Advertisement
Conference on 'optimising pharmaceutical patent lifecycles' PDF Print E-mail
User Rating: / 0
PoorBest 

Legal IQ, a division of IQPC, is organizing an interactive two-day conference, "Optimising Pharmaceutical Patent Lifecycles," in London, on April 29, 2008

The conference will focus on how to maximize product revenues and yet avoid anti-competitive issues through strategic patent lifecycle management.

The conference will cover hot topics such as

  • How to maintain a competitive advantage by integrating legal and commercial strategies to extend product lifecycles
  • How to update patent strategies by assessing the implications of current US and European case law,
  • How to prevent competition law violations and
  • How to maximize the commercial value of patents by strategically managing the interplay between generics and innovators

The focus will be on building a commercially sound patent lifecycle management strategy and reassessing the impact that patent practices have on competition law positions in Europe and the US.

The conference is specifically designed to answer pressing questions from top figures at EPO, UK IPO, Indian PO and USPTO, provide practical lessons in how to apply the key patent lifecycle extension strategies, and ensure that attendees maximise the efficiency of potential collaborations between innovators and generics.

 

 
< Prev   Next >

Retailing

Kmart Pharmacy has launch of the American Fare Dollar Program, which offers pharmacy customers a choice of 10 over-the-counter (OTC) medications from Kmart's proprietary American Fare brand for only…     Readmore

Image

Outsourcing

The pharmaceutical manufacturers in the United States have attacked the proposed pharma policy of India saying that it would contravene the stated goal of liberalizing the sector, and sought some…     Readmore

Image

Homeopathy

The Homeopatic manufacturing units must fulfill the conditions stated by the government of India under 67-G     Readmore

FDA

Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics,  has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light(R) HER2…     Readmore

Biotechnology

Attractive incentives and tax soaps offered by the Malaysian government for the biotech and research based companies is luring some major Indian pharmaceutical players to set up units in…     Readmore

Nanotechnology

The UK Royal Commission has issued a report on the spread of nanomaterials, stating that “urgent action [is] needed on testing and regulation”. In its report the Commission found…     Readmore

Packaging

Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and…     Readmore